Dicloxacillin and flucloxacillin: Pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration
- 1 March 1995
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 23 (2) , 107-112
- https://doi.org/10.1007/bf01833876
Abstract
The pharmacokinetics of dicloxacillin and flucloxacillin were studied in 12 healthy volunteers after oral administration. The participants received a single dose of either dicloxacillin (0.5 g, 0.75 g or 1.0 g) or flucloxacillin (0.75 g) in a cross-over fashion. Antibiotic concentrations were determined in serum and urine by bioassay and followed for 8 and 24 h, respectively. The three dicloxacillin dosages showed no significant differences for the serum elimination half-lives (t1/2β, median: 72 min). Comparing 0.75 g flucloxacillin with the same dose of dicloxacillin, no significant differences between the values of Cmax, t1/2β and AUC were found. Protein binding as determined by ultrafiltration in pooled serum was 94.7–96.2% for flucloxacillin and 96.4–97.2% for dicloxacillin. The serum bactericidal titers were similar for the two drugs. In conclusion, dicloxacillin and flucloxacillin showed similar pharmacokinetic behavior after 0.75 g doses in human volunteers. Bei 12 gesunden freiwilligen Probanden wurde die Pharmakokinetik von Dicloxacillin und Flucloxacillin nach oraler Gabe untersucht. Die Probanden erhielten eine Einzeldosis Dicloxacillin (0,5 g, 0,75 g oder 1,0 g) oder Flucloxacillin (0,75 g) im Überkreuz-Verfahren. Die Antibiotikakonzentrationen wurden im Serum und Urin über einen Zeitraum von 8 und 24 Stunden verfolgt und mittels Bioassay bestimmt. Die drei Dosierungen von Dicloxacillin ließen keine signifikanten Unterschiede in den Serum-Eliminations-Halbwertzeiten (t1/2β; median 72 min) erkennen. Der Vergleich der 0,75 g Dosis von Flucloxacillin mit derselben Dosis von Dicloxacillin zeigte keine signifikanten Unterschiede für die Werte Cmax, t1/2β und AUC. Die Eiweißbindung wurde durch Ultrafiltration in gepoolten Seren mit 94,7–96,2% für Flucloxacillin und von 96,4–97,2% für Dicloxacillin ermittelt. Beide Medikamente zeigten ähnliche Serumbakterizidietiter. Dicloxacillin wies folglich nach Gabe von 0,75 g bei Probanden ähnliche pharmakokinetische Eigenschaften auf wie Flucloxacillin.Keywords
This publication has 13 references indexed in Scilit:
- PLASMA-PROTEIN BINDING OF DICLOXACILLIN - EFFECTS OF AGE AND DISEASES1987
- Single-dose Pharmacokinetics of Dicloxacillin in Healthy Subjects of Young and Old AgeScandinavian Journal of Infectious Diseases, 1986
- Pharmacokinetics of beta-lactam antibiotics.1984
- Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysis subjectsClinical Pharmacology & Therapeutics, 1976
- Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.Published by Wiley ,1975
- Flucloxacillin: A new semisynthetic isoxazolyl penicillinClinical Pharmacology & Therapeutics, 1972
- Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and DicloxacillinBMJ, 1970
- Mechanisms Responsible for the Blood Level Differences of Isoxazolyl PenicillinsArchives of internal medicine (1960), 1968
- Serum Levels, Urinary Recovery, and Safety of Dicloxacillin, a New Semisynthetic Penicillin, in Normal VolunteersThe Journal of Clinical Pharmacology and The Journal of New Drugs, 1967
- Clinical, laboratory, and pharmacological studies of dicloxacillin.1966